Impact of macroprolactin on galactorrhea and the rate of patients possibly affected by macroprolactin

• Published in: ENDOCRINE JOURNAL Vol. 65; no. 2; pp. 203 - 211
• Main Authors: Aisaka, Kohzo, Tsuchiya, Fujiko, Sueta, Masami, Itabashi, Kana, Nose, Sayaka, Hasegawa, Akiko, Obata, Seiichiro, Hiraike, Haruko, Yokoyama, Tetsuhiko
• Format: Journal Article
• Language: English
• Published: Japan The Japan Endocrine Society 01-01-2018; Japan Science and Technology Agency
• Subjects: Adult; Blood Chemical Analysis - methods; Blood Chemical Analysis - standards; Female; Galactorrhea; Galactorrhea - blood; Galactorrhea - diagnosis; Galactorrhea - epidemiology; Genital Diseases, Female - blood; Genital Diseases, Female - complications; Genital Diseases, Female - epidemiology; Gynecology; Health risk assessment; Humans; Hyperprolactinemia; Hyperprolactinemia - blood; Hyperprolactinemia - diagnosis; Hyperprolactinemia - epidemiology; Macroprolactin; Obstetrics; Patients; Polyethylene glycol precipitation; Population studies; Pregnancy; Pregnancy Complications - blood; Pregnancy Complications - diagnosis; Pregnancy Complications - epidemiology; Prevalence; Prolactin; Prolactin - analysis; Prolactin - blood; Reference Values; Retrospective Studies; ROC Curve; Polyethylene glycol precipitation; Prevalence; Macroprolactin; Galactorrhea
• ISSN: 0918-8959; 1348-4540
• DOI: 10.1507/endocrj.EJ17-0358

The clinical influence of macroprolactin (MPRL) is not clearly understood and the rate of patients potentially affected by MPRL is unknown. We investigated the influence of MPRL on the onset of galactorrhea and estimated the rate of patients with a proportion of MPRL fraction that may possibly affect galactorrhea. Data of patients with obstetric or gynecological symptoms who had undergone PRL fractionation testing were retrospectively analyzed. To evaluate factors influencing galactorrhea, a multivariate logistic regression analysis was performed and the adjusted odds ratios of MPRL for galactorrhea were calculated. Cutoff values for the total PRL level and the proportion of MPRL fractions for galactorrhea were determined by ROC analysis using a multivariate logistic model. The prevalence of patients with a proportion of MPRL fraction greater than or equal to the cutoff value for galactorrhea was estimated. The median proportion of MPRL fraction was 30.1% and increased as PRL level increased. Total PRL and MPRL had a significant influence on the onset of galactorrhea and the adjusted odds ratio was 1.09 in total PRL and 0.94 in MPRL. The rate of patients with a proportion of MPRL fraction that may possibly affect galactorrhea was estimated to be 33.5% of the study population, and thus found to be twelve times or more the number of macroprolactinemia patients. Future prospects for hyperprolactinemia may require diagnostic criteria using free prolactin levels and so MPRL fraction measurement is important for the diagnosis and treatment of patients with obstetric and gynecological symptoms.